WO2010084508A3 - Process for the preparation of type i, type ii and type iii crystalline prulifloxacin - Google Patents

Process for the preparation of type i, type ii and type iii crystalline prulifloxacin Download PDF

Info

Publication number
WO2010084508A3
WO2010084508A3 PCT/IN2009/000718 IN2009000718W WO2010084508A3 WO 2010084508 A3 WO2010084508 A3 WO 2010084508A3 IN 2009000718 W IN2009000718 W IN 2009000718W WO 2010084508 A3 WO2010084508 A3 WO 2010084508A3
Authority
WO
WIPO (PCT)
Prior art keywords
type
preparation
prulifloxacin
iii crystalline
methyl
Prior art date
Application number
PCT/IN2009/000718
Other languages
French (fr)
Other versions
WO2010084508A2 (en
Inventor
Rajiv Sakhardande
Manmohan Nimbalkar
Navin Khatri
Priti Jayesh Bhayani
Ravindra Prajapati
Azadkumar Sharma
Ashok Darekar
Original Assignee
Elder Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elder Pharmaceuticals Ltd. filed Critical Elder Pharmaceuticals Ltd.
Publication of WO2010084508A2 publication Critical patent/WO2010084508A2/en
Publication of WO2010084508A3 publication Critical patent/WO2010084508A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Abstract

The invention relates to the process for the preparation of type I, type II and type III crystals of 6-fluoro-1-methyl-7-[4-[(5- methyl-2-oxo- 1,3 -dioxol-4-yl)methyl]- 1 -piperazinyl] -4-oxo- 1 H,4H- [1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid.
PCT/IN2009/000718 2009-01-14 2009-12-10 Process for the preparation of type i, type ii and type iii crystalline prulifloxacin WO2010084508A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN96/MUM/2009 2009-01-14
IN96MU2009 2009-01-14

Publications (2)

Publication Number Publication Date
WO2010084508A2 WO2010084508A2 (en) 2010-07-29
WO2010084508A3 true WO2010084508A3 (en) 2010-12-23

Family

ID=42356277

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000718 WO2010084508A2 (en) 2009-01-14 2009-12-10 Process for the preparation of type i, type ii and type iii crystalline prulifloxacin

Country Status (1)

Country Link
WO (1) WO2010084508A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2498107A (en) 2010-06-30 2013-07-03 Cipla Ltd Crystalline form of prulifloxacin and processes for its preparation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008111018A2 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Process for the preparation of crystals of prulifloxacin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008111018A2 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Process for the preparation of crystals of prulifloxacin

Also Published As

Publication number Publication date
WO2010084508A2 (en) 2010-07-29

Similar Documents

Publication Publication Date Title
WO2009115562A3 (en) Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
HK1189221A1 (en) 5,6-dihydro-imidazo[1,2-a] pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (bace) -(bace) 56--[12-a]-8-
WO2009145456A3 (en) Heterocyclic derivatives
WO2010141796A3 (en) PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
WO2012007345A3 (en) Substituted imidazo[1,2-a]pyrimidines and -pyridines
ZA201302128B (en) 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace)
WO2008121687A3 (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
HK1173151A1 (en) Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(tr ifluoromethyl)-1,4-dihydroquinoline-3-carboxamide n-(4-(7-[221]-7-)-2-())-4--5-()-1 4--3-
AP3346A (en) Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
IL204693A0 (en) Imidazo[1, 2 - a] pyrimidine derivatives for the treatment of diseases such as diabetes
IL215074A0 (en) Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
WO2010011772A3 (en) Tri-cyclic pyrazolopyridine kinase inhibitors
WO2008109156A3 (en) Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
ZA201105896B (en) [1,2,4] triazolo [1,5-a] pyridines as kinase inhibitors
IL202248A (en) 3-(imidazol-2-yl)-pyrazolo[3,4-b]pyridine-1-acetic acid 4-(3-methoxy-4-chloro-phenyl) piperazin-1-yl ester, methods for its manufacture and its use for the preparation of medicaments
WO2009130604A3 (en) Solid state forms of deferasirox salts and process for the preparation thereof
WO2005100368A3 (en) Stable amorphous cefdinir
IL219861A0 (en) Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate and its purification for use as pharmaceutically active compound
WO2010056656A3 (en) Preparation of crystalline palonosetron hydrochloride
WO2010092015A8 (en) Urea triazolo [1, 5-a] pyridine derivatives as pi3k inhibitors
WO2009117381A3 (en) Preparation of montelukast and its salts
WO2012080195A3 (en) Polymorphic forms of asenapine maleate and processes for their preparation
WO2006134491A3 (en) New crystalline form of moxifloxacin hydrochloride and process for its preparation
WO2011042860A3 (en) New derivatives of thieno[2,3-b]pyridine and 5,6,7,8-tetrahydrothieno[2,3-b]quinoline in particular useful in the treatment of malaria
WO2010039825A3 (en) Imidazo [1, 2-a] pyridine compounds as receptor tyrosine kinase inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09838711

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09838711

Country of ref document: EP

Kind code of ref document: A2